Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Synergy Chc's Business Segments
Synergy Chc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2025
Reportable Segments
3
Largest Segment
Nutraceuticals
Total Revenue
$ 8
Countrys Reported
3
Revenue Share by Reportable Segment - Q1 FY2025
- Nutraceuticals81.3%
- Consumer Goods18.4%
- Beverages0.4%
Revenue by Reportable Segment - Q1 FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Nutraceuticals | $ 7 | 81.3% |
| Consumer Goods | $ 2 | 18.4% |
| Beverages | $ 0 | 0.4% |
Revenue Share by Country - Q1 FY2025
- US91.2%
- CA8%
- MX0%
Revenue by Geographic Country - Q1 FY2025
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 7 | 91.2% |
| CA | $ 1 | 8% |
| MX | $ 0 | 0% |
Revenue by Product & Service Category - Q1 FY2025
- Product81.6%
- Retail66.2%
- Online33.8%
- License18.4%
Revenue by Product & Service Category - Q1 FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 7 | 81.6% |
| Retail | $ 5 | 66.2% |
| Online | $ 3 | 33.8% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Synergy Chc dataset.
Description of Synergy Chc
Synergy Chc Corp is a global biotechnology company that specializes in the development and commercialization of innovative healthcare products. The company is focused on bringing cutting-edge solutions to market to address unmet medical needs and improve patients' quality of life.
Synergy Chc Corp has an extensive portfolio of products that span various therapeutic areas, including oncology, cardiovascular, respiratory, neurology, and infectious diseases. The company's research and development efforts are centered around developing novel drugs and therapies that are backed by robust scientific data and have the potential to be game-changers in their respective fields.
One of the key strengths of Synergy Chc Corp is its strong commitment to research and innovation. The company invests heavily in its R&D activities, conducting clinical trials and collaborating with leading academic institutions and research organizations. This ensures that Synergy Chc Corp stays at the forefront of scientific advancements and can bring novel treatments to market faster.
In addition to its R&D efforts, Synergy Chc Corp also places a strong emphasis on ensuring the safety and efficacy of its products. The company has a rigorous quality control system in place to ensure that all products meet the highest standards of safety and are subjected to comprehensive testing and regulatory approvals before they are made available to patients.
Synergy Chc Corp is also dedicated to global accessibility and affordability of its products. The company partners with healthcare providers, governments, and patient advocacy groups to ensure that its treatments reach underserved populations and are accessible to all those who need them. This commitment to global health equity is central to Synergy Chc Corp's mission of improving patients' lives worldwide.
Furthermore, Synergy Chc Corp is also actively involved in corporate social responsibility initiatives. The company channels a portion of its profits towards philanthropic activities, supporting healthcare infrastructure development, education, and community programs in underserved areas.
Synergy Chc Corp's global presence and diverse product portfolio have positioned it as a leader in the biotechnology industry. The company continues to expand its operations through strategic partnerships, acquisitions, and collaborations, enabling it to leverage synergies and accelerate the development and commercialization of innovative healthcare solutions.
Overall, Synergy Chc Corp's extensive research capabilities, commitment to quality, global accessibility, and corporate social responsibility efforts make it a trusted and respected player in the healthcare industry, continually striving to meet the evolving needs of patients and healthcare providers worldwide.
Synergy Chc Corp has an extensive portfolio of products that span various therapeutic areas, including oncology, cardiovascular, respiratory, neurology, and infectious diseases. The company's research and development efforts are centered around developing novel drugs and therapies that are backed by robust scientific data and have the potential to be game-changers in their respective fields.
One of the key strengths of Synergy Chc Corp is its strong commitment to research and innovation. The company invests heavily in its R&D activities, conducting clinical trials and collaborating with leading academic institutions and research organizations. This ensures that Synergy Chc Corp stays at the forefront of scientific advancements and can bring novel treatments to market faster.
In addition to its R&D efforts, Synergy Chc Corp also places a strong emphasis on ensuring the safety and efficacy of its products. The company has a rigorous quality control system in place to ensure that all products meet the highest standards of safety and are subjected to comprehensive testing and regulatory approvals before they are made available to patients.
Synergy Chc Corp is also dedicated to global accessibility and affordability of its products. The company partners with healthcare providers, governments, and patient advocacy groups to ensure that its treatments reach underserved populations and are accessible to all those who need them. This commitment to global health equity is central to Synergy Chc Corp's mission of improving patients' lives worldwide.
Furthermore, Synergy Chc Corp is also actively involved in corporate social responsibility initiatives. The company channels a portion of its profits towards philanthropic activities, supporting healthcare infrastructure development, education, and community programs in underserved areas.
Synergy Chc Corp's global presence and diverse product portfolio have positioned it as a leader in the biotechnology industry. The company continues to expand its operations through strategic partnerships, acquisitions, and collaborations, enabling it to leverage synergies and accelerate the development and commercialization of innovative healthcare solutions.
Overall, Synergy Chc Corp's extensive research capabilities, commitment to quality, global accessibility, and corporate social responsibility efforts make it a trusted and respected player in the healthcare industry, continually striving to meet the evolving needs of patients and healthcare providers worldwide.